The levels of SOD and GSH-Px were significantly elevated in the phr 100 (SOD: 11.84 ± 1.9 U/mg; p < 0.01 versus BPH group, GSH-Px: 44.8 ± 7.6 U/g; p < 0.01 versus BPH group) and fina groups (SOD: 10.3 ± 1.5 U/mg; p < 0.05 versus BPH group, GSH-Px: 38.3 ± 5.7 U/g; p < 0.05 versus BPH group) in comparison with the BPH group. The gene discussed is SOD1; the disease is benign prostatic hyperplasia.